Search | ECR Journal

AER

CFR

ECR

ICR3

JAPSC

USC

ECR is the official journal of the

About ECR

Editorial Board

Submission Guidelines

Journal Policies

Current Volume

Previous Volumes

Special Collections

Videos

Podcasts

Submit Article

Search results

Findings from an Apolipoprotein B-Based Genetic Analysis

New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL

News

Added: 1 year ago Source: Radcliffe Cardiology

AUTHOR: Brad WilsonIn a study published in the Journal of the American College of Cardiology (JACC), Dr Elias Björnson and his colleagues demonstrated that lipoprotein(a) (Lp(a)) is approximately six times more atherogenic than low-density lipoprotein (LDL) per particle.Lp(a) is a lipoprotein particle that has long been recognised as a causal factor for coronary heart disease (CHD). However,… View more

ACC 24 Late-Breaker Discussion: The AEGIS-II Trial

Video

Author(s): Harriette Van Spall , Michael C Gibson Added: 1 year ago

ACC 2024 — Late-breaker host, Dr Harriette Van Spall and Principal Investigator, Dr C Michael Gibson discuss the AEGIS-II trial (CSL Behring) (NCT03473223).This phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study investigated the efficacy and safety of an apolipoprotein A-I (apoA-I), CSL112 in patients with acute coronary syndrome (ACS). Investigators enrolled… View more

Prevention & Chronic Conditions

MI/ACS

ESC 24: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Video

Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 8 months ago

ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.Day 4 Highlights:00:19… View more

Imaging & Diagnostics

Prevention & Chronic Conditions

ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Video

Author(s): Brian Bergmark Added: 1 year ago

ACC.24 — Dr Brian Bergmark (Brigham and Women's Hospital, Harvard Medical School, US) joins us in this interview to discuss the findings of a study into olezarsen, previously known as AKCEA-APOCIII-LRx, in patients with hypertriglyceridemia and atherosclerotic cardiovascular disease (ASCVD), with or without severe hypertriglyceridemia (NCT05355402).This multicenter, randomized, double-blind study… View more

Prevention & Chronic Conditions